All In Biotech

Drug Trial Radar · NCT00790998

Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection

A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety And Tolerability Study Of Orally Administered Moxidectin In Subjects Infected With Onchocerca Volvulus

Last checked: Nov 19, 2026Latest source record: Jan 31, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,497 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,497

Actual

Start

Apr 2009

Primary completion

Feb 2012

Study completion May 2012

Sponsor

Lead sponsor
Medicines Development for Global HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
World Health Organization
First posted
Nov 14, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3 study comparing the efficacy, safety and tolerability of moxidectin and ivermectin in subjects infected with Onchocerca volvulus, which is the parasite that causes river blindness. Subjects participating in the study will be randomly assigned (by a 2 to1 ratio) to receive one orally-administered dose of either moxidectin or ivermectin.

Conditions

  • Onchocerciasis

Interventions

  • MoxidectinDrug

    Single dose of moxidectin 2 mg oral tablet x 4

  • IvermectinDrug

    Single dose of ivermectin 3 mg oral tablet x 2, 3 or 4

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. skin microfilaria density (mf/mg)Time frame: 12 months

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • Centre de Recherche Clinique de Butembo - Université Catholique du Graben

    Butembo, Democratic Republic of the Congo

  • Centre de Recherche en Maladies Tropicales de l'Ituri

    Rethy, Democratic Republic of the Congo

  • Onchocerciasis Chemotherapy Research Center

    Hohoe, Ghana

  • Liberian Institute for Biomedical Research Clinical Research Center

    Bolahun, Lofa County, Liberia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.